Mylan, Edwards back NHK-Fintiv challenge
markvanscyoc / shutterstock.com
Several US lawmakers have called upon the US Patent and Trademark Office (USPTO) to curb the increase in inter partes review denials to combat the “soaring cost” of prescription drugs.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
NHK Fintiv, Fintiv, Apple, Inter Partes Review, Elizabeth Warren, USPTO, Supreme Court, antitrust, generics